Experimental and Molecular Pathology Journal Citation Rate 2026

ISSN 0014-4800 eISSN 1096-0945 Elsevier BV US

Q2 Quartile Open Access Established Impact

About Experimental and Molecular Pathology
{# Self-contained "answer block": one dense, LLM-quotable paragraph stating every core fact with an explicit as-of year, server-rendered and unique per journal. This is the canonical fact statement — other sections add narrative, they do not restate these numbers. #}

Experimental and Molecular Pathology (EMP) is a peer-reviewed academic journal covering Cell Adhesion Molecules Research and Diverse Scientific and Economic Studies, published by Elsevier BV in US, catalogued under ISSN 0014-4800 (e-ISSN 1096-0945). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 2.85 (Q2 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It is fully open access, with an Article Processing Charge (APC) of approximately $1900 USD. OpenAlex records 5,110 works and 121,267 citations, with an h-index of 112.

Experimental and Molecular Pathology Citation Rate 2026 — In Context

Experimental and Molecular Pathology has a 2025 2-Year Citation Rate (OpenAlex) of 2.85, placing it in the Q2 quartile within the Cell Adhesion Molecules Research research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.

As a fully open-access publication, Experimental and Molecular Pathology makes all articles freely available to readers for an Article Processing Charge of approximately $1900 USD.

Researchers looking to publish in Experimental and Molecular Pathology should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Experimental and Molecular Pathology against similar journals in the field, use our journal comparison tool.

Submission Tips for Experimental and Molecular Pathology
  • Budget $1900 for the Article Processing Charge. Check if your institution or funder covers OA fees.
  • This journal covers Cell Adhesion Molecules Research, Diverse Scientific and Economic Studies, Educational Robotics and Engineering. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Experimental and Molecular … Compares
Citation Rate vs Field Avg
-32%
Field avg: 4.2
APC vs Field Avg
-44%
Field avg: $3407

Compared against 152 journals in the same research areas.

ISSN (Print) 0014-4800
ISSN (Online) 1096-0945
Publisher Elsevier BV
Country United States
APC / Cost $1900 USD
In-depth profile & metrics

Experimental and Molecular Pathology is published by Elsevier BV and based in United States. It publishes open access with an article-processing charge of USD 1900.

In our subject taxonomy, Experimental and Molecular Pathology is classified under Cell Adhesion Molecules Research, Diverse Scientific and Economic Studies, Educational Robotics and Engineering and Human auditory perception and evaluation.

Experimental and Molecular Pathology is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.

Its most recent citation rate stands at 2.849.

Research Areas
Links
Frequently Asked Questions about Experimental and Molecular Pathology

Experimental and Molecular Pathology does not hold a Clarivate (JCR) Impact Factor on JournalsHub. Its 2-year citation rate, computed from OpenAlex open citation data, is 2.849 — an open proxy for citation impact, not the licensed JCR Impact Factor.

Yes, Experimental and Molecular Pathology is an open access journal.

The Article Processing Charge (APC) for Experimental and Molecular Pathology is $1900 USD.

Experimental and Molecular Pathology is published by Elsevier BV.

Experimental and Molecular Pathology shows strong legitimacy signals: it is indexed in DOAJ, OpenAlex. Indexing in recognised databases such as Scopus and DOAJ is a reliable indicator of a peer-reviewed, non-predatory journal, because predatory titles are typically excluded from them. Always confirm the journal's scope and editorial board fit your work before submitting.

The ISSN of Experimental and Molecular Pathology is 0014-4800. Its electronic ISSN (eISSN) is 1096-0945.

Experimental and Molecular Pathology sits in the Q2 quartile based on its latest impact factor of 2.85, ranked across all journals in our database.
Live Indexing Status
Updated April 2026

Track real-time indexing metrics to ensure this journal meets your academic requirements.

OpenAlex
Verified
DOAJ
Indexed OA
Predatory Check
Clean
Citation Rate
2.849
2-Year Citation Rate (OpenAlex) · 2025
Historical Trend
Initial data points only
Citation Rate by Year
Year Value Source
2025 2.849 2-Year Mean Citedness (OpenAlex)

Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.

Related Journals in Your Field

Metadata

Last updated: Apr 24, 2026

Updated by: openalex_bulk

OpenAlex ID: S111757857

Get weekly updates for Cell Adhesion Molecules Research journals

Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now
Compare 0 Open → Clear
Save your viewing history
You've browsed several journals this session. Sign in to track them in one place and get weekly impact-factor updates.
Save with Google